Search research articles
Contact Us
Filters
Showing results (1-10 of 443) with videos related to
Page
of 45
Sort By:
Pigment Cell & Melanoma Research
|
July 26, 2011
Melanoma response and resistance - taking it to the tumor bank
John M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Building upon the standard of care in adjuvant therapy of high-risk melanoma
John M Kirkwood
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
Response to letter to the editor on "Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76K trial"
John M Kirkwood
Nature Reviews. Clinical Oncology
|
September 26, 2020
Cancer vaccine induces potent T cell responses - but is it enough?
Anjali Rohatgi, John M Kirkwood
Cytokine & Growth Factor Reviews
|
August 19, 2007
Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma
Stergios Moschos, John M Kirkwood
Clinical Journal of Oncology Nursing
|
July 25, 2017
Collaborative Care in Melanoma: The Essential Role of the Nurse
John M Kirkwood, Antoni Ribas
Pigment Cell & Melanoma Research
|
March 24, 2009
Highlights from the perspectives in melanoma XII conference
John M Kirkwood, Alexander Eggermont
Current Opinion in Oncology
|
June 18, 2009
Predictors of response to interferon therapy
Helen Gogas, John M Kirkwood
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
CCR 20th Anniversary Commentary: MAPK/ERK Pathway Inhibition in Melanoma-Kinase Inhibition Redux
Diwakar Davar, John M Kirkwood
Cancer Treatment and Research
|
November 26, 2015
Adjuvant Therapy of Melanoma
Diwakar Davar, John M Kirkwood
Page
of 45
Search research articles
Search
Showing results (1-10 of 443) with videos related to
Sort By:
Page
of 45
Pigment Cell & Melanoma Research
|
July 26, 2011
Melanoma response and resistance - taking it to the tumor bank
John M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Building upon the standard of care in adjuvant therapy of high-risk melanoma
John M Kirkwood
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
Response to letter to the editor on "Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76K trial"
John M Kirkwood
Nature Reviews. Clinical Oncology
|
September 26, 2020
Cancer vaccine induces potent T cell responses - but is it enough?
Anjali Rohatgi, John M Kirkwood
Cytokine & Growth Factor Reviews
|
August 19, 2007
Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma
Stergios Moschos, John M Kirkwood
Clinical Journal of Oncology Nursing
|
July 25, 2017
Collaborative Care in Melanoma: The Essential Role of the Nurse
John M Kirkwood, Antoni Ribas
Pigment Cell & Melanoma Research
|
March 24, 2009
Highlights from the perspectives in melanoma XII conference
John M Kirkwood, Alexander Eggermont
Current Opinion in Oncology
|
June 18, 2009
Predictors of response to interferon therapy
Helen Gogas, John M Kirkwood
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
CCR 20th Anniversary Commentary: MAPK/ERK Pathway Inhibition in Melanoma-Kinase Inhibition Redux
Diwakar Davar, John M Kirkwood
Cancer Treatment and Research
|
November 26, 2015
Adjuvant Therapy of Melanoma
Diwakar Davar, John M Kirkwood
Page
of 45